REVIEW   

Minerva Obstetrics and Gynecology 2022 August;74(4):364-76

DOI: 10.23736/S2724-606X.21.04881-8

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Clinical pharmacology of progestins

Anna CAPOZZI ✉, Giovanni SCAMBIA, Stefano LELLO

Department of Women and Child Health, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy

INTRODUCTION: In this paper, we report general pharmacological profile and major biological activities of natural progesterone (P) and progestins. The aim of this article consists of synthesizing the principal aspects of pharmacology and metabolism of P and progestins related to the clinical consequences of their use.
EVIDENCE ACQUISITION: We review scientific literature on the topic “progestins,” evaluating the most relevant data from original articles, reviews, and meta-analyses.
EVIDENCE SYNTHESIS: Progestins represent a specific class of synthetic analogues of P clinically employed (alone or associated with estrogens) to manage several gynecological conditions, for instance multiple abortions, luteal phase defect, premenstrual syndrome, abnormal uterine bleeding, endometriosis, and menopause (for hormone replacement therapy). Besides their use in the field of contraception, many non-contraceptive benefits of estroprogestins are mostly due to the activities of progestins. Pharmacological characteristics, dosage and individual metabolism could be listed among the principal aspects influencing their clinical effects.
CONCLUSIONS: The choice of each progestin according to its pharmacological profile is crucial for the appropriate management of any gynecological condition. An aware knowledge of these compounds is fundamental to hone medical practice.

KEY WORDS: Progestins; Progesterone; Pharmacology; Pharmacokinetics